Kathrin Mandery
Impact in
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Inflammatory mediators and NSAID effects
- Pharmacological Effects of Natural Compounds
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 11
-
- Inflammatory mediators and NSAID effects 4
- Co-authors
- Martin F. Fromm (12 shared papers)Hartmut Glaeser (11 shared papers)Jörg König (5 shared papers)Ingrid Schmidt (6 shared papers)Markus Keiser (2 shared papers)Fabian Müller (1 shared paper)Werner Siegmund (1 shared paper)Heinrich Sticht (2 shared papers)
- Journals
- British Journal of Pharmacology (2 papers)Biochemical Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)Naunyn-Schmiedeberg s Archives of Pharmacology (1 paper)European Journal of Pharmaceutical Sciences (1 paper)
- Partner nations
- GermanySwitzerlandCzechia
In The Last Decade
Kathrin Mandery
12 papers receiving 516 citations
Peers
Comparison fields: 5 of 79
- Pharmacology 131
- Oncology 333
- Biochemistry 60
- Pediatrics, Perinatology and Child Health 137
- Pharmacology 65
Countries citing papers authored by Kathrin Mandery
This map shows the geographic impact of Kathrin Mandery's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathrin Mandery with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathrin Mandery more than expected).
Fields of papers citing papers by Kathrin Mandery
This network shows the impact of papers produced by Kathrin Mandery. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathrin Mandery. The network helps show where Kathrin Mandery may publish in the future.
Co-authors
The 23 scholars most cited alongside Kathrin Mandery, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 113 | |
| 2 | 2013 | 82 | |
| 3 | 2012 | 55 | |
| 4 | 2010 | 47 | |
| 5 | 2011 | 39 | |
| 6 | 2014 | 38 | |
| 7 | 2010 | 38 | |
| 8 | 2011 | 35 | |
| 9 | 2009 | 35 | |
| 10 | 2011 | 21 | |
| 11 | 2020 | 12 | |
| 12 | 2014 | 4 |
About Kathrin Mandery
Kathrin Mandery is a scholar working on Oncology, Pharmacology, Surgery, Molecular Biology and Pediatrics, Perinatology and Child Health, having authored 12 papers that have together received 519 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Inflammatory mediators and NSAID effects (4 papers), Pharmacological Effects and Toxicity Studies (3 papers), Amino Acid Enzymes and Metabolism (3 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Metabolism and Genetic Disorders (1 paper), Trace Elements in Health (1 paper) and Glaucoma and retinal disorders (1 paper). The work is most often cited by research in Pharmacology (131 citations), Oncology (333 citations), Biochemistry (60 citations), Pediatrics, Perinatology and Child Health (137 citations) and Pharmacology (65 citations). Kathrin Mandery has collaborated with scholars based in Germany, Switzerland and Czechia. Frequent co-authors include Martin F. Fromm, Hartmut Glaeser, Jörg König, Ingrid Schmidt, Markus Keiser, Fabian Müller, Werner Siegmund, Heinrich Sticht, Ulrich Klotz and Ursula Schlötzer‐Schrehardt. Their work appears in journals such as British Journal of Pharmacology, Biochemical Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Naunyn-Schmiedeberg s Archives of Pharmacology and European Journal of Pharmaceutical Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.